The Food and Drug Administration on Friday granted vaping company Juul Labs permission to market an updated version of its e‑cigarette, marking the first time the company can sell a new device since its introduction more than a decade ago. The cleared product, to be marketed as Juul2, includes an optional app-based age-verification feature intended to prevent underage use.
Regulatory context and company history
The FDA’s decision allows Juul to reenter the market with a redesigned device and updated versions of its tobacco- and menthol-flavored cartridges. The agency emphasized, however, that the authorization is not an endorsement and that people who do not smoke should not use Juul or other electronic cigarettes.
Juul has faced years of scrutiny over youth vaping. The company has laid off hundreds of employees and reached roughly $3 billion in settlements with government and private plaintiffs related to teen use of its products. In 2019 the company discontinued several flavors, including mango, mint and creme, which regulators and public-health officials said had been popular with teens.
What the FDA cited and what the device offers
In its review of company-submitted studies, the FDA noted data suggesting smokers who completely switch to Juul products can reduce their exposure to certain carcinogens and harmful chemicals found in combustible cigarettes. Those studies reported that between 20% and 50% of smokers who used Juul products were able to stop smoking after six weeks, with quitting rates varying by flavor used.
"a portfolio of flavors — beyond tobacco and menthol — that are targeted to adult nicotine consumers."
The quoted line above was released by Juul Chief Executive K.C. Crosthwaite in a company statement announcing plans to seek authorization for additional flavors aimed at adult smokers.
Juul2 introduces an optional age-gating system that can require users to verify their age via an online application before the device can be unlocked. The age-verification feature is not mandatory, but represents a technological measure the company says is designed to curb underage access.
Broader regulatory landscape
The FDA has previously authorized a limited number of e‑cigarette products as potentially helpful to adult smokers trying to quit or reduce cigarette consumption. Earlier this year, the agency authorized the first fruit-flavored electronic cigarettes intended for adult smokers, a move that represented a notable policy shift.
Federal officials continue to stress that authorization of a specific product is distinct from a general endorsement of vaping. The agency’s communications reiterated public-health guidance discouraging non-smokers, particularly youth, from using e‑cigarettes.
Potential consequences and industry implications
The clearance gives Juul a pathway to reestablish a presence in retail and consumer markets after several years of setbacks. For smokers, regulators pointed to potential reductions in exposure to harmful cigarette smoke if a complete switch to vaping occurs. At the same time, public-health advocates and lawmakers will likely scrutinize whether optional technological safeguards such as app-based age verification are sufficient to prevent underage use.
Industry observers note several immediate implications:
- Market impact: Juul can resume sales of a new device and updated cartridges, potentially regaining market share lost during litigation and product pullbacks.
- Regulatory precedent: The authorization adds to a small set of e‑cigarette approvals by the FDA and may shape future review standards regarding harm reduction and youth protections.
- Public-health debate: Health officials and advocacy groups will weigh the benefits of reduced carcinogen exposure for adult smokers against risks of renewed youth uptake.
| Item | Detail |
|---|---|
| Device | Juul2 (updated Juul e‑cigarette) |
| Flavors authorized | Tobacco and menthol (updated cartridges) |
| Quit rates reported | 20%–50% at six weeks in company studies |
| Company settlements | About $3 billion |
The authorization will likely prompt close attention from state and local regulators, health advocates and members of Congress focused on youth vaping. Juul’s stated intention to seek authorization for a broader set of flavors targeted at adult nicotine consumers may be a focal point for future regulatory review and public debate over how to balance harm-reduction goals with preventing underage use.
The FDA’s action neither endorses vaping for non-smokers nor resolves long-standing controversies surrounding flavored e‑cigarettes and their appeal to adolescents. Still, for adult smokers considering alternatives to combustible tobacco, the clearance provides another regulated option that federal officials say can reduce exposure to some harmful chemicals when used as a complete substitute for cigarettes.
